Tivity Health Reports Third-Quarter 2018 Results

Go back to Tivity Health Reports Third-Quarter 2018 Results

Tivity Health (TVTY) PT Lowered to $41 at Chardan Capital Markets

November 6, 2018 9:39 AM EST

Chardan Capital Markets analyst Steven Wardell lowered the price target on Tivity Health (NASDAQ: TVTY) to $41.00 (from $43.00) while maintaining a Buy rating.

... More

Tivity Health, Inc. (TVTY) Tops Q3 EPS by 2c, Updates FY Guidance

November 5, 2018 4:14 PM EST

Tivity Health, Inc. (NASDAQ: TVTY) reported Q3 EPS of $0.59, $0.02 better than the analyst estimate of $0.57. Revenue for the quarter came in at $151.5 million versus the consensus estimate of $153.84 million.

GUIDANCE:

Tivity Health, Inc. sees FY2018 EPS of $2.15-$2.20, versus the... More